Logo image
The in vitro Antitumour Activity of Substituted Dibutyl-1,3,2-dioxastannolanes
Journal article   Peer reviewed

The in vitro Antitumour Activity of Substituted Dibutyl-1,3,2-dioxastannolanes

S C Ng, P G Parsons, K Y Sim, C J Tranter, Rodney H White and David James Young
Applied Organometallic Chemistry, Vol.11(7), pp.577-581
1997
url
https://doi.org/10.1002/(SICI)1099-0739(199707)11:7<577::AID-AOC612>3.0.CO;2-SView
Published Version

Abstract

antitumour dioxastannolanes human cell lines
Six dibutyl-l,3,2-dioxastannolanes, including two enantiomeric pairs, exhibited greater in vitro antitumour activity towards a variety of human tumour cell lines than cisplatin but with little discrimination, suggesting hydrolysis to a common cytotoxic intermediate. A cell line hypersensitive to mitochondrial inhibitors (CI80-13S) was not sensitive to any of the test compounds, suggesting that cell mechanisms other than, or in addition to, mitochondrial function are targeted by tin antitumour agents. A pigmented melanoma cell line (MM418c5) was resistant to the test compounds, which were found to be sequestered by melanin. This resistance was not observed with triphenyltin hydroxide. © 1997 by John Wiley & Sons, Ltd.

Details

Metrics

2 File views/ downloads
914 Record Views

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Web Of Science research areas
Chemistry, Applied
Chemistry, Inorganic & Nuclear

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Logo image